Peter C. Kahr

1.1k total citations · 1 hit paper
21 papers, 774 citations indexed

About

Peter C. Kahr is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Peter C. Kahr has authored 21 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Peter C. Kahr's work include Cardiac pacing and defibrillation studies (5 papers), Cardiac Arrhythmias and Treatments (5 papers) and Congenital Heart Disease Studies (5 papers). Peter C. Kahr is often cited by papers focused on Cardiac pacing and defibrillation studies (5 papers), Cardiac Arrhythmias and Treatments (5 papers) and Congenital Heart Disease Studies (5 papers). Peter C. Kahr collaborates with scholars based in Switzerland, Germany and United Kingdom. Peter C. Kahr's co-authors include Larissa Fabritz, Nigel A. Brown, Ilaria Piccini, Paulus Kirchhof, James F. Martin, Lele Li, Todd R. Heallen, Ge Tao, Brad A. Amendt and Mahdis Rahmani and has published in prestigious journals such as Nature, New England Journal of Medicine and PLoS ONE.

In The Last Decade

Peter C. Kahr

18 papers receiving 763 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid

2023 124 citations Pablo García‐Pavía, Fabian aus dem Siepen et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Peter C. Kahr

Since Specialization

Citations

This map shows the geographic impact of Peter C. Kahr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Kahr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Kahr more than expected).

Fields of papers citing papers by Peter C. Kahr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Kahr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Kahr. The network helps show where Peter C. Kahr may publish in the future.

Co-authorship network of co-authors of Peter C. Kahr

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Kahr. A scholar is included among the top collaborators of Peter C. Kahr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Kahr. Peter C. Kahr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Nonprogression Is a Form of Response to Cardiac Resynchronization Therapy 2025 ·JACC Advances ·Sander Trenson, Peter C. Kahr, Bert Vandenberk, Matthias Schindler, (unknown), Ardan M. Saguner, Andreas J. Flammer, Frank Ruschitzka, Fırat Duru, Jan Steffel, Stephan Winnik	0
2	Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patients 2024 ·Vascular Pharmacology ·Stefano Ministrini, (unknown), Alexander Akhmedov, (unknown), Yustina M. Puspitasari, Maria Franzini, (unknown), Douglas Cannie, Perry Elliott, Peter C. Kahr, (unknown), Richard Kobza, Stefan Toggweiler, Thomas F. Lüscher, Giovanni G. Camici, Simon F. Stämpfli	2
3	Prediction of Cardiac ATTR Depletion by NI006 (ALXN2220) Using Mechanistic PK/PD Modeling 2024 ·Clinical Pharmacology & Therapeutics ·Aubin Michalon, (unknown), Matthias Macháček, (unknown), Chandrasekhar Udata, (unknown), (unknown), Christoph Höck, Roger M. Nitsch, Peter C. Kahr, Jan Grimm	1
4	Long-term safety and efficacy of antibody ALXN2220 for depletion of cardiac amyloid transthyretin: results of treatment beyond 12 months in the open-label extension of study NI006-101 2024 ·European Heart Journal ·Peter van der Meer, Olivier Lairez, Erwan Donal, Fabian aus dem Siepen, Arnt V. Kristen, Thibaud Damy, Cristina Quarta, Michele Mercuri, Roger M. Nitsch, Jan Grimm, Sergio Rey, M. Tichý, Peter C. Kahr, (unknown), Pablo García‐Pavía	0
5	Lateral QRS amplitude is independently associated with outcome after cardiac resynchronization therapy: Advancing patient selection? 2024 ·Heart Rhythm ·Sander Trenson, Peter C. Kahr, (unknown), (unknown), (unknown), Bert Vandenberk, Jürgen Duchenne, Ahmed S Beela, Ivan Stanković, Gábor Vörös, Andreas J. Flammer, Matthias Schindler, Ardan M. Saguner, Rik Willems, Frank Ruschitzka, Jan Steffel, (unknown), Jens‐Uwe Voigt, Stephan Winnik	0
6	Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid breakdown → 2023 ·New England Journal of Medicine ·Pablo García‐Pavía, Fabian aus dem Siepen, Erwan Donal, Olivier Lairez, Peter van der Meer, Arnt V. Kristen, Michele Mercuri, Aubin Michalon, Robert J. Frost, Jan Grimm, Roger M. Nitsch, Christoph Höck, Peter C. Kahr, Thibaud Damy	124
7	A novel transgenic Cre allele to label mouse cardiac conduction system 2021 ·Developmental Biology ·Peter C. Kahr, Ge Tao, Zachary A. Kadow, Matthew C. Hill, Min Zhang, Shuang Li, James F. Martin	4
8	“Second line medications” for supraventricular arrhythmias in children: In‐hospital efficacy and adverse events during treatment initiation of sotalol and flecainide 2021 ·Journal of Cardiovascular Electrophysiology ·Peter C. Kahr, Brady S. Moffett, Christina Y. Miyake, Jeffrey J. Kim, Santiago O. Valdés	4
9	Differential Effect of Cardiac Resynchronization Therapy in Patients with Diabetes Mellitus: A Long-Term Retrospective Cohort Study 2020 ·ESC Heart Failure ·Peter C. Kahr, Sander Trenson, Matthias Schindler, (unknown), Philipp A. Kaufmann, (unknown), Daniel Höfer, (unknown), Alexander Breitenstein, Ardan M. Saguner, Andreas J. Flammer, Frank Ruschitzka, Jan Steffel, Stephan Winnik	6
10	Long-term follow-up after cardiac resynchronization therapy-optimization in a real-world setting: A single-center cohort study 2020 ·Cardiology Journal ·(unknown), Peter C. Kahr, Frank Ruschitzka, Jan Steffel, Andreas J. Flammer, Stephan Winnik	2
11	Atrial Fibrillation: A New Indicator for Advanced Colorectal Neoplasia in Screening Colonoscopy 2019 ·Journal of Clinical Medicine ·Peter C. Kahr, (unknown), Ursula Huber-Schönauer, Christian Schmied, Laurent Haegeli, Slayman Obeid, Sarah Eder, (unknown), Elmar Aigner, Christian Datz, David Niederseer	2
12	Coronary sinus reducer device for patients with refractory angina 2018 ·Cardiovascular Medicine ·Peter C. Kahr, Andreas A. Giannopoulos, Ronny R. Buechel, Oliver Gaemperli, Shmuel Banai, Slayman Obeid, Thomas F. Lüscher	1
13	Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury 2016 ·Nature ·Ge Tao, Peter C. Kahr, Yuka Morikawa, Min Zhang, Mahdis Rahmani, Todd R. Heallen, Lele Li, Zhao Sun, Eric N. Olson, Brad A. Amendt, James F. Martin	218
14	Changes in Myocardial Contractility and Electromechanical Interval During the First Month of Life in Healthy Neonates 2015 ·Pediatric Cardiology ·Peter C. Kahr, Maike Kahr, (unknown), Ramesh Agarwal, Shyam S. Kothari, Anitá Saxena, Sivasubramanian Ramakrishnan	8
15	Analysis of associations between congenital heart defect complexity and health-related quality of life using a meta-analytic strategy 2015 ·International Journal of Cardiology ·Peter C. Kahr, Robert Radke, Stefan Orwat, Helmut Baumgartner, Gerhard‐Paul Diller	47
16	Long-term natural history and postoperative outcome of double-chambered right ventricle—Experience from two tertiary adult congenital heart centres and review of the literature 2014 ·International Journal of Cardiology ·Peter C. Kahr, Rafael Alonso-González, Aleksander Kempny, Stefan Orwat, Anselm Uebing, Konstantinos Dimopoulos, Lorna Swan, Helmut Baumgartner, Michael Α. Gatzoulis, Gerhard‐Paul Diller	24
17	Need for Psychosocial Assistance in Patients Undergoing Cardiothoracic Surgery Evaluated by a Seven-Item Questionnaire 2014 ·The Thoracic and Cardiovascular Surgeon ·Peter C. Kahr, Hans H. Scheld, (unknown), (unknown)	3
18	Almanac 2014: congenital heart disease 2014 ·Heart ·Peter C. Kahr, Gerhard‐Paul Diller	5
19	Value of Speckle-tracking Echocardiography and MRI-based Feature Tracking Analysis in Adult Patients after Fontan-type Palliation 2013 ·Congenital Heart Disease ·Renate Schmidt, Stefan Orwat, Aleksander Kempny, Pia Schuler, Robert Radke, Peter C. Kahr, (unknown), Helmut Baumgartner, Gerhard‐Paul Diller	39
20	Systematic Analysis of Gene Expression Differences between Left and Right Atria in Different Mouse Strains and in Human Atrial Tissue 2011 ·PLoS ONE ·Peter C. Kahr, Ilaria Piccini, Larissa Fabritz, Boris Greber, Hans R. Schöler, Hans H. Scheld, A. Hoffmeier, Nigel A. Brown, Paulus Kirchhof	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact